Simplify Asset Management Inc. Sells 14,768 Shares of GE HealthCare Technologies Inc. $GEHC

Simplify Asset Management Inc. reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.3% during the first quarter, HoldingsChannel.com reports. The fund owned 39,260 shares of the company’s stock after selling 14,768 shares during the quarter. Simplify Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $2,795,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter worth about $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies during the 4th quarter valued at approximately $27,000. Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies in the 4th quarter worth approximately $27,000. Montag A & Associates Inc. raised its holdings in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $65.57 on Friday. The company has a market cap of $29.83 billion, a PE ratio of 15.69, a price-to-earnings-growth ratio of 1.78 and a beta of 0.72. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The company has a 50 day simple moving average of $63.70 and a two-hundred day simple moving average of $73.29. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 3.35%.

Insider Transactions at GE HealthCare Technologies

In related news, Director Kevin Lobo acquired 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director owned 14,363 shares in the company, valued at $921,817.34. The trade was a 229.20% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Rodney F. Hochman bought 1,618 shares of GE HealthCare Technologies stock in a transaction that occurred on Tuesday, May 12th. The stock was purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ? increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 21,847 shares of company stock worth $1,361,355 over the last three months. 0.36% of the stock is currently owned by insiders.

Analysts Set New Price Targets

GEHC has been the subject of a number of recent research reports. Wells Fargo & Company cut their target price on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and dropped their price objective for the stock from $75.00 to $69.00 in a research note on Thursday, May 21st. Barclays reduced their target price on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. HSBC decreased their target price on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Finally, Royal Bank Of Canada assumed coverage on GE HealthCare Technologies in a research report on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price objective on the stock. Ten analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $80.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.